Literature DB >> 3662904

Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

.   

Abstract

During eligibility screening for the Diabetes Control and Complications Trial, we compared stereoscopic color fundus photography and stereoscopic fluorescein angiography in the detection of diabetic retinopathy in 320 patients (mean age, 24 years [SD, eight years]) with insulin-dependent diabetes (mean duration, 7.0 years [SD, 4.0 years]) and no or mild diabetic retinopathy. Of 153 patients classified as having no retinopathy according to color photographs of seven standard 30 degrees fields of both eyes, 21% of the patients had evidence of retinopathy (mostly one or two microaneurysms in one eye) on review of fluorescein angiograms, including two standard 30 degrees fields in each eye. Of those patients with no retinopathy detected on angiograms, 19% had retinopathy on review of color photographs. When used in conjunction with color photography, angiography allows a modest increase in sensitivity to the earliest signs of retinopathy, a gain potentially useful in some research applications, although not of demonstrated value in patient management.

Entities:  

Mesh:

Year:  1987        PMID: 3662904     DOI: 10.1001/archopht.1987.01060100046022

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  20 in total

1.  Within-subject assessment of foveal avascular zone enlargement in different stages of diabetic retinopathy using en face OCT reflectance and OCT angiography.

Authors:  Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2018-11-05       Impact factor: 3.732

2.  Identification of individual microaneurysms: a comparison between fluorescein angiograms and red-free and colour photographs.

Authors:  T Hellstedt; E Vesti; I Immonen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Imaging of diabetic retinopathy and diabetic macular edema.

Authors:  Ronald P Danis; Larry D Hubbard
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

4.  First microangiographic abnormalities in childhood diabetes--types of lesions.

Authors:  C Verougstraete; D Toussaint; J De Schepper; M Haentjens; H Dorchy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

5.  Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity.

Authors:  Michael A Klufas; Samir N Patel; Michael C Ryan; Mrinali Patel Gupta; Karyn E Jonas; Susan Ostmo; Maria Ana Martinez-Castellanos; Audina M Berrocal; Michael F Chiang; R V Paul Chan
Journal:  Ophthalmology       Date:  2015-05-28       Impact factor: 12.079

6.  The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.

Authors:  Mary Gilbert Lawrence
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Automated quantitative characterisation of retinal vascular leakage and microaneurysms in ultra-widefield fluorescein angiography.

Authors:  Justis P Ehlers; Kevin Wang; Amit Vasanji; Ming Hu; Sunil K Srivastava
Journal:  Br J Ophthalmol       Date:  2017-04-21       Impact factor: 4.638

Review 8.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

9.  Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.

Authors:  G L Ong; L G Ripley; R S B Newsom; A G Casswell
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

10.  Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.